Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1992 Aug;66(2):391–395. doi: 10.1038/bjc.1992.275

Somatostatin binding in normal and malignant human gastrointestinal mucosa.

G V Miller 1, S M Farmery 1, L F Woodhouse 1, J N Primrose 1
PMCID: PMC1977804  PMID: 1354473

Abstract

Somatostatin is a regulatory peptide implicated in the control of cellular proliferation in epithelial tissues and this regulation may occur directly via membrane bound receptor activation. The aim of this study was to investigate somatostatin binding in human gastrointestinal cancer and normal mucosa. Plasma membranes were prepared from specimens of tumour and normal mucosa from 51 patients undergoing surgical resection for malignancy (28 gastric, 23 colorectal). Using a competitive displacement assay, specific 125I-tyrosine-11-somatostatin-14 binding to plasma membranes was assessed and and characterised in terms of receptor affinity (Kd) and maximum binding capacity (Bmax) as determined by Scatchard analysis. Specific low affinity (Kd = 166 nM), high capacity (Bmax = 1.2 pmol mg-1 protein) somatostatin binding was demonstrated in 22 of the gastric cancers and 17 of the colorectal cancers (Kd = 140 nM, Bmax = 1.8 pmol mg-1 protein). Similar affinity and binding capacity was demonstrable in normal mucosal samples. High affinity receptors for somatostatin were expressed by one gastric carcinoma (Kd = 0.9 nM; Bmax = 0.23 pmol mg-1 protein). Thus, low affinity, high capacity binding is a common feature of gastrointestinal tumours and normal mucosa, and high affinity receptors may occasionally be demonstrated. The functional significance of these low affinity binding sites requires elucidation to determine whether long-acting somatostatin analogues may have therapeutic benefit in gastrointestinal malignancy.

Full text

PDF
391

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adrian T. E., Barnes A. J., Long R. G., O'Shaughnessy D. J., Brown M. R., Rivier J., Vale W., Blackburn A. M., Bloom S. R. The effect of somatostatin analogs on secretion of growth, pancreatic, and gastrointestinal hormones in man. J Clin Endocrinol Metab. 1981 Oct;53(4):675–681. doi: 10.1210/jcem-53-4-675. [DOI] [PubMed] [Google Scholar]
  2. Bleiberg H. The future of adjuvant treatment in gastrointestinal cancer. Eur J Surg Oncol. 1990 Jun;16(3):189–194. [PubMed] [Google Scholar]
  3. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  4. CRILE G., Jr The endocrine dependency of certain thyroid cancers and the danger that hypothyroidism may stimulate their growth. Cancer. 1957 Nov-Dec;10(6):1119–1137. doi: 10.1002/1097-0142(195711/12)10:6<1119::aid-cncr2820100607>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  5. Cai R. Z., Szoke B., Lu R., Fu D., Redding T. W., Schally A. V. Synthesis and biological activity of highly potent octapeptide analogs of somatostatin. Proc Natl Acad Sci U S A. 1986 Mar;83(6):1896–1900. doi: 10.1073/pnas.83.6.1896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Conlon J. M., Whittaker J., Hammond V., Alberti K. G. Metabolism of somatostatin and its analogues by the liver. Biochim Biophys Acta. 1981 Oct 12;677(2):234–242. doi: 10.1016/0304-4165(81)90090-8. [DOI] [PubMed] [Google Scholar]
  7. Czernik A. J., Petrack B. Somatostatin receptor binding in rat cerebral cortex. Characterization using a nonreducible somatostatin analog. J Biol Chem. 1983 May 10;258(9):5525–5530. [PubMed] [Google Scholar]
  8. Engstrom P. F., Lavin P. T., Douglass H. O., Jr, Brunner K. W. Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Eastern Cooperative Oncology Group study (EST 3275). Cancer. 1985 May 1;55(9):1868–1873. doi: 10.1002/1097-0142(19850501)55:9<1868::aid-cncr2820550904>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  9. Fielding J. W., Fagg S. L., Jones B. G., Ellis D., Hockey M. S., Minawa A., Brookes V. S., Craven J. L., Mason M. C., Timothy A. An interim report of a prospective, randomized, controlled study of adjuvant chemotherapy in operable gastric cancer: British Stomach Cancer Group. World J Surg. 1983 May;7(3):390–399. doi: 10.1007/BF01658089. [DOI] [PubMed] [Google Scholar]
  10. Hierowski M. T., Liebow C., du Sapin K., Schally A. V. Stimulation by somatostatin of dephosphorylation of membrane proteins in pancreatic cancer MIA PaCa-2 cell line. FEBS Lett. 1985 Jan 7;179(2):252–256. doi: 10.1016/0014-5793(85)80529-9. [DOI] [PubMed] [Google Scholar]
  11. Horwitz K. B., McGuire W. L. Predicting response to endocrine therapy in human breast cancer: a hypothesis. Science. 1975 Aug 29;189(4204):726–727. doi: 10.1126/science.168640. [DOI] [PubMed] [Google Scholar]
  12. Howatson A. G., Carter D. C. Pancreatic carcinogenesis-enhancement by cholecystokinin in the hamster-nitrosamine model. Br J Cancer. 1985 Jan;51(1):107–114. doi: 10.1038/bjc.1985.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ikuyama S., Nawata H., Kato K., Karashima T., Ibayashi H., Nakagaki H. Specific somatostatin receptors on human pituitary adenoma cell membranes. J Clin Endocrinol Metab. 1985 Oct;61(4):666–671. doi: 10.1210/jcem-61-4-666. [DOI] [PubMed] [Google Scholar]
  14. Kirkegaard P., Olsen P. S., Nexø E., Holst J. J., Poulsen S. S. Effect of vasoactive intestinal polypeptide and somatostatin on secretion of epidermal growth factor and bicarbonate from Brunner's glands. Gut. 1984 Nov;25(11):1225–1229. doi: 10.1136/gut.25.11.1225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lehy T., Dubrasquet M., Bonfils S. Effect of somatostatin on normal and gastric-stimulated cell proliferation in the gastric and intestinal mucosae of the rat. Digestion. 1979;19(2):99–109. doi: 10.1159/000198330. [DOI] [PubMed] [Google Scholar]
  16. Liebow C., Reilly C., Serrano M., Schally A. V. Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. Proc Natl Acad Sci U S A. 1989 Mar;86(6):2003–2007. doi: 10.1073/pnas.86.6.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. McMichael A. J., Potter J. D. Reproduction, endogenous and exogenous sex hormones, and colon cancer: a review and hypothesis. J Natl Cancer Inst. 1980 Dec;65(6):1201–1207. [PubMed] [Google Scholar]
  18. Munson P. J., Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 1980 Sep 1;107(1):220–239. doi: 10.1016/0003-2697(80)90515-1. [DOI] [PubMed] [Google Scholar]
  19. Osei K., O'Dorisio T. M. Malignant insulinoma: effects of a somatostatin analog (compound 201-995) on serum glucose, growth, and gastro-entero-pancreatic hormones. Ann Intern Med. 1985 Aug;103(2):223–225. doi: 10.7326/0003-4819-103-2-223. [DOI] [PubMed] [Google Scholar]
  20. Rake M. O., Mallinson C. N., Cocking J. B., Cwynarski M. T., Fox C. A., Wass V. J., Diffey B. L., Jackson G. A. Chemotherapy in advanced gastric cancer: a controlled, prospective, randomised multi-centre study. Gut. 1979 Sep;20(9):797–801. doi: 10.1136/gut.20.9.797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Reubi J. C., Häcki W. H., Lamberts S. W. Hormone-producing gastrointestinal tumors contain a high density of somatostatin receptors. J Clin Endocrinol Metab. 1987 Dec;65(6):1127–1134. doi: 10.1210/jcem-65-6-1127. [DOI] [PubMed] [Google Scholar]
  22. Reubi J. C., Lang W., Maurer R., Koper J. W., Lamberts S. W. Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system. Cancer Res. 1987 Nov 1;47(21):5758–5764. [PubMed] [Google Scholar]
  23. Reubi J. C., Maurer R. Different ionic requirements for somatostatin receptor subpopulations in the brain. Regul Pept. 1986 Jul;14(4):301–311. doi: 10.1016/0167-0115(86)90172-2. [DOI] [PubMed] [Google Scholar]
  24. Reubi J. C., Waser B., Sheppard M., Macaulay V. Somatostatin receptors are present in small-cell but not in non-small-cell primary lung carcinomas: relationship to EGF-receptors. Int J Cancer. 1990 Feb 15;45(2):269–274. doi: 10.1002/ijc.2910450211. [DOI] [PubMed] [Google Scholar]
  25. Reyl-Desmars F., Lewin M. J. Evidence for an intracellular somatostatin receptor in pancreas: a comparative study with reference to gastric mucosa. Biochem Biophys Res Commun. 1982 Dec 31;109(4):1324–1331. doi: 10.1016/0006-291x(82)91922-2. [DOI] [PubMed] [Google Scholar]
  26. Reyl F. J., Lewin M. J. Intracellular receptor for somatostatin in gastric mucosal cells: decomposition and reconstitution of somatostatin-stimulated phosphoprotein phosphatases. Proc Natl Acad Sci U S A. 1982 Feb;79(4):978–982. doi: 10.1073/pnas.79.4.978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Sirinek K. R., Levine B. A., Moyer M. P. Pentagastrin stimulates in vitro growth of normal and malignant human colon epithelial cells. Am J Surg. 1985 Jan;149(1):35–39. doi: 10.1016/s0002-9610(85)80006-4. [DOI] [PubMed] [Google Scholar]
  28. Sjödin L., Englund L. J., Mårdh S. Binding of cholecystokinin and somatostatin to isolated porcine gastric mucosal cells and effects on aminopyrine uptake. Acta Physiol Scand. 1990 Mar;138(3):369–376. doi: 10.1111/j.1748-1716.1990.tb08859.x. [DOI] [PubMed] [Google Scholar]
  29. Srikant C. B., Patel Y. C. Somatostatin receptors: identification and characterization in rat brain membranes. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3930–3934. doi: 10.1073/pnas.78.6.3930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Townsend C. M., Jr, Singh P., Thompson J. C. Gastrointestinal hormones and gastrointestinal and pancreatic carcinomas. Gastroenterology. 1986 Oct;91(4):1002–1006. doi: 10.1016/0016-5085(86)90707-9. [DOI] [PubMed] [Google Scholar]
  31. Upp J. R., Jr, Singh P., Townsend C. M., Jr, Thompson J. C. Clinical significance of gastrin receptors in human colon cancers. Cancer Res. 1989 Jan 15;49(2):488–492. [PubMed] [Google Scholar]
  32. Watson S. A., Durrant L. G., Morris D. L. Growth-promoting action of gastrin on human colonic and gastric tumour cells cultured in vitro. Br J Surg. 1988 Apr;75(4):342–345. doi: 10.1002/bjs.1800750416. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES